Encontrados 4 documentos, a visualizar página 1 de 1
ABO-Incompatible Liver Transplantation in Acute Liver Failure: A Single Portugu...
Mendes, M; Ferreira, AC; Ferreira, A; Remédio, F; Aires, I; Cordeiro, A; Mascarenhas, A; Martins, A; Pereira, P; Glória, H; Perdigoto, R; Veloso, JINTRODUCTION: ABO-incompatible liver transplantation (ABOi LT) is considered to be a rescue option in emergency transplantation. Herein, we have reported our experience with ABOi LT including long-term survival and major complications in these situations. PATIENT AND METHODS: ABOi LT was performed in cases of severe hepatic failure with imminent death. The standard immunosuppression consisted of basiliximab, c...
Treatment of Hepatitis C Virus Infection in Kidney Transplant Recipients: Case ...
Caeiro, F; Baptista, V; Rodrigues, N; Carvalho, D; Aires, I; Remédio, F; Nolasco, FChronic hepatitis C virus (HCV) infection exists in a large proportion of patients undergoing renal transplantation. Nowadays it is not considered to be an absolute contraindication to transplantation; however, it is associated with an increased risk for the patient and accounts for a shorter half-life of the renal allograft. We present three transplant recipients who displayed serious hepatic dysfunction after...
Sirolimus-Induced Drug Fever in a Renal Transplant Patient: a Case Report
Aires, I; Carvalho, D; Remédio, F; Possante, M; Ferreira, A; Pinto, JR; Nolasco, F; Ribeiro Santos, JHerein we have described the case of a male renal transplant recipient who developed drug fever apparently related to sirolimus. He had been stable under an immunosuppressive regimen of tacrolimus and mycophenolate mofetil, but developed acute cellular rejection at 5 years after transplantation due to noncompliance. Renal biopsy showed marked interstitial fibrosis, and immunosuppression was switched from mycoph...
Brain Natriuretic Peptide Levels Predict Morbidity and Mortality in Haemodialys...
Matias, P; Jorge, C; Aires, I; Lage, H; Gil, C; Gomes, F; Arranhado, E; Ferreira, ABackground: Brain natriuretic peptide is a predictor of mortality in multiple cardiovascular diseases but its value in patients with chronic kidney disease is still a matter of debate. Patients and methods: We studied 48 haemodialysis patients with mean age 70.0±13.9 years,62.5% female, 43.8% diabetics, with a mean haemodialysis time of 38.1±29.3 months. To evaluate the role of brain natriuretic peptide as a pr...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||